Replies to post #117053 on Biotech Values

[rkrw]

I think IFN-L is an intriguing program and there could be a place for it even if there is an all oral combination in the future.

Keep in mind, MEDX and ZGEN weren't forced to agree to be bought out. I guess, bummer. :)